BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22114854)

  • 1. Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.
    Fanouriakis A; Boumpas DT; Bertsias GK
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):437-51. PubMed ID: 22114854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologicals for the treatment of systemic lupus erythematosus?
    Gunnarsson I; van Vollenhoven RF
    Ann Med; 2012 May; 44(3):225-32. PubMed ID: 21495789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus: novel therapies in clinical development.
    Chugh PK
    Eur J Intern Med; 2012 Apr; 23(3):212-8. PubMed ID: 22385876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belimumab: review of use in systemic lupus erythematosus.
    Boyce EG; Fusco BE
    Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
    Lo MS; Tsokos GC
    Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus.
    Dennis GJ
    Clin Pharmacol Ther; 2012 Jan; 91(1):143-9. PubMed ID: 22130121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
    Mosak J; Furie R
    Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
    Sthoeger Z; Sharabi A; Mozes E
    J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New targets in systemic lupus (part 2/2).
    Sifuentes Giraldo WA; GarcĂ­a Villanueva MJ; Boteanu AL; Lois Iglesias A; Zea Mendoza AC
    Reumatol Clin; 2012; 8(5):263-9. PubMed ID: 22483664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy.
    Driver CB; Ishimori M; Weisman MH
    Ann Rheum Dis; 2008 Oct; 67(10):1374-81. PubMed ID: 17720723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of biologic therapies in systemic lupus erythematosus.
    Bruce IN
    Curr Opin Rheumatol; 2010 May; 22(3):273-7. PubMed ID: 20177385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring outcomes in systemic lupus erythematosus clinical trials.
    Strand V; Chu AD
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):455-68. PubMed ID: 21831027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on B-cell targeted therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Biol Ther; 2014 Jun; 14(6):773-88. PubMed ID: 24588110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Belimumab for systemic lupus erythematosus: a practice-based view.
    Parodis I; Axelsson M; Gunnarsson I
    Lupus; 2013 Apr; 22(4):372-80. PubMed ID: 23553780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapy for systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Discov Med; 2010 Jan; 9(44):20-3. PubMed ID: 20102681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
    Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
    Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.